MarketInOut Stock Screener Log In | Sign Up
 

AbbVie Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/04/2026 16:00
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization366,965 mln
Float1,765 mln
Earnings Date07/24/2026

EPS

2.05
Stretched

P / E

102
Highly speculative

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.49
Borderline

1-Year Forecast

249
Attractive

Relative Strength

81 / 100
Strongly outperforming

Business Description

AbbVie is a global pharmaceutical company founded in 2012 and based in North Chicago, Illinois, that develops and sells treatments across a wide range of medical conditions. Its portfolio includes medicines for blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, and eye conditions, as well as therapies for hepatitis C and digestive health. The company also has a strong presence in aesthetics, offering products such as Botox and the Juvederm collection for cosmetic and skin-related treatments.

Key Fundamentals

EPS2.05
P/E102
RPS34.50
ROIC11.30
ROA3.12
Interest Cover6.94
EBITDA, mln17,629
EV / EBITDA24.39
EV / EBIT45.31
Revenue, mln61,160
EV / Revenue7.03

Financial Strength

Altman Z-Score1.98
Piotroski F-Score 7 / 9
Beneish M-Score-2.49
Price to Intrinsic Value2.00
1-Year Target Price249
Shiller PE Ratio44.47
Short Ratio3.06
Short % of Float1.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.46% 93 / 100   
1 Month 0.5% 30 / 100   
2 Months -4.93% 24 / 100   
6 Months -7.32% 17 / 100   
1 Year 11.13% 39 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us